Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nesa Kazemifard
Observed names:
Kazemifard, Nesa,
N. Kazemifard
Institutions:
Research Institute for Gastroenterology and Liver Diseases,
Shahid Beheshti University of Medical Sciences
Observed institutions:
Isfahan University of Medical Sciences,
Research Institute for Gastroenterology and Liver Diseases,
Shahid Beheshti University,
Shahid Beheshti University of Medical Sciences
ORCID:
0000-0002-9555-6006
Observed ORCID:
0000-0002-9555-6006
OpenAlex ID:
A5006820575
Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs)
2022
·
Seyed Mobin Khoramjoo
, Nesa Kazemifard
, et al.
·
Frontiers in Medicine
·
65
PDF
The critical role of gut-brain axis microbiome in mental disorders
2023
·
Kimia Basiji
, Azadeh Aghamohammadi Sendani
, et al.
·
Metabolic Brain Disease
·
58
Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
2022
·
Nesa Kazemifard
, Abolfazl Dehkohneh
, et al.
·
Frontiers in Medicine
·
54
PDF
Ulcerative colitis: the healing power of macrophages
2024
·
Nesa Kazemifard
, Nafiseh Golestani
, et al.
·
Tissue Barriers
·
24
PDF
Exploring the Anti-Inflammatory and Antioxidative Potential of Selenium Nanoparticles Biosynthesized by Lactobacillus casei 393 on an Inflamed Caco-2 Cell Line
2024
·
Azadeh Aghamohammadi Sendani
, Maryam Farmani
, et al.
·
Cell Biochemistry and Biophysics
·
13
Obesity, a challenge in the management of inflammatory bowel diseases
2022
·
Mohsen Rajabnia
, Shideh Moftakhari Hajimirzaei
, et al.
·
Immunologic Research
·
13
Fistula in Crohn’s disease: classification, pathogenesis, and treatment options
2025
·
Kimia Basiji
, Nesa Kazemifard
, et al.
·
Tissue Barriers
·
12
Serological response to SARS‐CoV ‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization
2022
·
Shaghayegh Baradaran Ghavami
, Shabnam Shahrokh
, et al.
·
JGH Open
·
9
Molecular mechanisms and therapeutic effects of natural products in inflammatory bowel disease
2024
·
Azadeh Aghamohammadi Sendani
, Maryam Farmani
, et al.
·
Clinical Nutrition Open Science
·
7
PDF
Acute Kidney Injury (AKI) in COVID-19: In silico Identification of LncRNA-MiRNA-Gene Networks and Key Transcription Factors
2023
·
Somayeh Hashemi Sheikhshabani
, Zeinab Amini-Farsani
, et al.
·
Current Pharmaceutical Design
·
7
Circulating tumor DNA applications in monitoring the treatment of metastatic colorectal cancer patients.
2019
·
Nesa Kazemifard
, Amir Sadeghi
, et al.
·
Gastroenterology and hepatology from bed to bench.
·
6
PDF
A prediction of the CRNDE role by modulating NF-κB pathway in inflammatory bowel disease (IBD)
2024
·
Nesa Kazemifard
, Maryam Farmani
, et al.
·
Biochemistry and Biophysics Reports
·
5
Meta‐analysis of microarray data to determine gene indicators involved in the cisplatin resistance in ovarian cancer
2023
·
Somayeh Hashemi Sheikhshabani
, Zeinab Amini‐Farsani
, et al.
·
Cancer Reports
·
5
PDF
Identification and validation of NF-kB pathway-related lncRNA upregulated in IBD patients
2023
·
Nesa Kazemifard
, Mohammad Kazemi
, et al.
·
Gene Reports
·
5
From signals to systems: the epigenetic-microbiome-mitochondrial axis in IBD pathogenesis
2026
·
Nesa Kazemifard
, Shabnam Shahrokh
, et al.
·
Gut Microbes
·
4
PDF
The Impact of Genetic Variation on Drug Response in Adult IBD : A Systematic Review
2025
·
Masomeh Askari
, Shaghayegh Baradaran Ghavami
, et al.
·
JGH Open
·
4
PDF
Personalized barrier recovery induced by Lactobacillus helveticus SBT2171 in an In Vitro model of ulcerative colitis-derived fecal supernatants
2026
·
Melika Khademi
, Nesa Kazemifard
, et al.
·
BMC Complementary Medicine and Therapies
·
2
Microbiota-targeted strategies in IBD: therapeutic promise of 2′-fucosyllactose and beyond
2025
·
Nicholas Fanous
, Nicholas J. Talley
, et al.
·
Therapeutic Advances in Gastroenterology
·
2
Exploring Fungal Biomarkers as Predictors of Treatment Response in Ulcerative Colitis Patients Receiving Anti-TNF Therapy
2025
·
Maryam Farmani
, Shaghayegh Baradaran Ghavami
, et al.
·
Research Square
·
1
PDF
Modulation of dysregulated ATG5 and ATG16L1 expression in IBD by Akkermansia muciniphila and its extracellular vesicles (EVs)
2026
·
Nesa Kazemifard
, Maryam Farmani
, et al.
·
Scientific Reports
PDF
Designing a multi-epitope vaccine against human cytomegalovirus: An immunoinformatic approach
2026
·
Kazemifard, Nesa
, Jahankhani, Kasra
, et al.
·
Gastroenterology and hepatology from bed to bench.
PDF
Redefining Neutrophil Function in Inflammatory Bowel Disease: From Tissue Injury to Immune Resolution
2026
·
Melika Khademi
, Nesa Kazemifard
, et al.
·
Molecular Biology Reports
Establishment of a Gene Expression Signature for Colitis-Associated Colorectal Cancer to Assess Cancer-Promoting Effects of Standard IBD Treatments
2026
·
Sarah Pashapour
, Nesa Kazemifard
, et al.
·
Research Square
PDF
Unraveling genetic signatures: the impact of SNPs on therapy response in inflammatory bowel disease patients.
2025
·
Nesa Kazemifard
, Masomeh Askari
, et al.
·
Gastroenterology and hepatology from bed to bench.
PDF
Microbiome-microRNA interactions in inflammatory bowel disease: insights from metagenomic and transcriptomic data analysis.
2025
·
Nesa Kazemifard
, Mohammad Hossein Norouzi-Beirami
, et al.
·
Gastroenterology and hepatology from bed to bench.
PDF
Show more works
View as search
Works count:
26
Citation count:
296
H-index:
8
I10-index:
7
Year
Topic
Type